This is the limited version of the Liquidia Technologies company profile: Join LinkedIn or Sign In to see more information.
Liquidia Technologies Inc. is a privately-held nanotechnology company that develops rationally designed particles and films for a variety of life and materials science applications. Within life sciences, Liquidia is focused on developing novel vaccines and Engineered Drug Therapies™ for nucleic acid delivery and inhaled therapeutics. The company was founded in 2004 on the discoveries of Professor Joseph DeSimone and colleagues at the University of North Carolina, Chapel Hill and is located in Research Triangle Park, North Carolina. www.liquidia.com.
Your Connections to Liquidia Technologies
Popular Profiles at Liquidia Technologies
Last edited by Business Development Associate at Liquidia Technologies
419 Davis Drive, Suite 100
Research Triangle Park, NC
27713
United States
Phone: 919-328-4400
Fax: 919-991-0827
| Top Schools |
| Univ. of North Carolina at Chapel Hill | 8% |
| Harvard Univ. | 6% |
| Duke Univ. | 6% |
|
Estimated based on LinkedIn Data
Career path for Liquidia Technologies employees
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about Liquidia Technologies. This page is not endorsed by or affiliated with Liquidia Technologies. For questions regarding LinkedIn Company Profiles, contact us.
